Hospital discharges for fever and neutropenia in pediatric cancer patients: United States, 2009
dc.contributor.author | Mueller, Emily L. | |
dc.contributor.author | Walkovich, Kelly J. | |
dc.contributor.author | Mody, Rajen | |
dc.contributor.author | Gebremariam, Achamyeleh | |
dc.contributor.author | Davis, Matthew M. | |
dc.contributor.department | Department of Pediatrics, Indiana University School of Medicine | en_US |
dc.date.accessioned | 2015-07-10T18:24:01Z | |
dc.date.available | 2015-07-10T18:24:01Z | |
dc.date.issued | 2015 | |
dc.description.abstract | Background Fever and neutropenia (FN) is a common complication of pediatric cancer treatment, but hospital utilization patterns for this condition are not well described. Methods Data were analyzed from the Kids’ Inpatient Database (KID), an all-payer US hospital database, for 2009. Pediatric FN patients were identified using: age ≤19 years, urgent or emergent admit type, non-transferred, and a combination of ICD-9-CM codes for fever and neutropenia. Sampling weights were used to permit national inferences. Results Pediatric cancer patients accounted for 1.5 % of pediatric hospital discharges in 2009 (n = 110,967), with 10.1 % of cancer-related discharges meeting FN criteria (n = 11,261). Two-fifths of FN discharges had a “short length of stay” (SLOS) of ≤3 days, which accounted for approximately $65.5 million in hospital charges. Upper respiratory infection (6.0 %) and acute otitis media (AOM) (3.7 %) were the most common infections associated with SLOS. Factors significantly associated with SLOS included living in the Midwest region (OR = 1.65, 1.22–2.24) or West region (OR 1.54, 1.11–2.14) versus Northeast, having a diagnosis of AOM (OR = 1.39, 1.03–1.87) or viral infection (OR = 1.63, 1.18–2.25) versus those without those comorbidities, and having a soft tissue sarcoma (OR = 1.47, 1.05–2.04), Hodgkin lymphoma (OR = 2.33, 1.62–3.35), or an ovarian/testicular tumor (OR = 1.76, 1.05–2.95) compared with patients without these diagnoses. Conclusion FN represents a common precipitant for hospitalizations among pediatric cancer patients. SLOS admissions are rarely associated with serious infections, but contribute substantially to the burden of hospitalization for pediatric FN. | en_US |
dc.eprint.version | Final published version | en_US |
dc.identifier.citation | Mueller, E. L., Walkovich, K. K., Mody, R., Gebremariam, A., & Davis, M. M. (2015). Hospital discharges for fever and neutropenia in pediatric cancer patients: United States, 2009. BMC cancer, 15(1), 388. | en_US |
dc.identifier.uri | https://hdl.handle.net/1805/6544 | |
dc.language.iso | en_US | en_US |
dc.relation.isversionof | 10.1186/s12885-015-1413-8 | en_US |
dc.relation.journal | BMC Cancer | en_US |
dc.rights | Attribution 3.0 United States | |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/us/ | |
dc.source | PMC | en_US |
dc.subject | oncology | en_US |
dc.subject | cancer | en_US |
dc.subject | pediatric | en_US |
dc.title | Hospital discharges for fever and neutropenia in pediatric cancer patients: United States, 2009 | en_US |
dc.type | Article | en_US |